MaSTherCell: Orgenesis completes sale of Masthercell subsidiary; receives approximately USD 127 million in net proceeds
Sale reflects culmination of successful CDMO strategy initiated in 2015 and 59 percent 5-year CAGR of Masthercell under Orgenesis' leadership
Read full article »
MaSTherCell is a contract development and manufacturing organization that develops cell and gene therapies for the healthcare industry.
Read more